| Owner |
Relationship |
Date |
Transaction |
Cost |
# Shares |
Value($) |
Total Shares |
Form |
Form 4 |
| Cox John |
EVP Pharmaceutical Oper & Tech |
May 03 |
Option Exercise |
$218.85 |
866 |
189,524 |
18,060 |
4 |
May 07, 01:33 PM |
| COVINO GREGORY F |
VP, Chief Accounting Officer |
May 01 |
Option Exercise |
$214.33 |
114 |
24,434 |
375 |
4 |
May 03, 03:10 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
May 01 |
Sale |
$215.39 |
1,598 |
344,193 |
50,509 |
4 |
May 03, 03:07 PM |
| Clancy Paul J |
Executive VP and CFO |
Apr 30 |
Sale |
$224.66 |
14,489 |
3,255,092 |
19,608 |
4 |
May 01, 03:45 PM |
| Clancy Paul J |
Executive VP and CFO |
Apr 29 |
Sale |
$219.71 |
9,123 |
2,004,414 |
21,576 |
4 |
May 01, 03:45 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Apr 01 |
Sale |
$193.66 |
1,598 |
309,469 |
52,107 |
4/A |
Apr 03, 12:31 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Apr 01 |
Sale |
$193.66 |
1,598 |
309,469 |
52,107 |
4 |
Apr 02, 01:23 PM |
| Mulligan Richard |
Director |
Mar 22 |
Sale |
$176.88 |
2,900 |
512,952 |
2,020 |
4 |
Mar 25, 02:20 PM |
| SHERWIN STEPHEN A |
Director |
Mar 22 |
Sale |
$176.88 |
1,500 |
265,320 |
2,655 |
4 |
Mar 25, 02:18 PM |
| Posner Brian S |
Director |
Mar 18 |
Sale |
$174.81 |
4,500 |
786,645 |
10,150 |
4 |
Mar 19, 03:15 PM |
| Mulligan Richard |
Director |
Mar 13 |
Sale |
$175.38 |
7,980 |
1,399,527 |
9,920 |
4 |
Mar 13, 02:56 PM |
| PAPADOPOULOS STELIOS |
Director |
Mar 11 |
Option Exercise |
$58.44 |
46,675 |
2,727,463 |
49,950 |
4 |
Mar 12, 02:22 PM |
| PAPADOPOULOS STELIOS |
Director |
Mar 11 |
Sale |
$172.26 |
46,675 |
8,040,003 |
18,916 |
4 |
Mar 12, 02:22 PM |
| Pawlicki Raymond |
SVP, Chief Information Officer |
Mar 01 |
Option Exercise |
$168.70 |
630 |
106,281 |
9,410 |
4 |
Mar 04, 04:42 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Mar 01 |
Sale |
$165.30 |
1,598 |
264,149 |
53,705 |
4 |
Mar 04, 04:40 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 23 |
Option Exercise |
$164.40 |
1,227 |
201,719 |
18,759 |
4 |
Feb 26, 01:26 PM |
| ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 23 |
Option Exercise |
$164.40 |
1,803 |
296,413 |
15,135 |
4 |
Feb 26, 01:25 PM |
| Pawlicki Raymond |
SVP, Chief Information Officer |
Feb 23 |
Option Exercise |
$164.40 |
722 |
118,697 |
10,040 |
4 |
Feb 26, 01:24 PM |
| Clancy Paul J |
Executive VP and CFO |
Feb 23 |
Option Exercise |
$164.40 |
2,021 |
332,252 |
30,699 |
4 |
Feb 26, 01:23 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Feb 13 |
Sale |
$163.39 |
1,598 |
261,097 |
55,303 |
4 |
Feb 14, 02:59 PM |
| Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 08 |
Option Exercise |
$164.44 |
831 |
136,650 |
4,548 |
4 |
Feb 12, 05:26 PM |
| Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 09 |
Option Exercise |
$164.44 |
861 |
141,583 |
5,511 |
4 |
Feb 12, 05:26 PM |
| Clancy Paul J |
Executive VP and CFO |
Feb 09 |
Option Exercise |
$164.44 |
1,731 |
284,646 |
28,439 |
4 |
Feb 12, 05:24 PM |
| Clancy Paul J |
Executive VP and CFO |
Feb 08 |
Option Exercise |
$164.44 |
899 |
147,832 |
25,478 |
4 |
Feb 12, 05:24 PM |
| Holtzman Steven H |
EVP Corporate Development |
Feb 08 |
Option Exercise |
$164.44 |
940 |
154,574 |
8,386 |
4 |
Feb 12, 05:22 PM |
| Pawlicki Raymond |
SVP, Chief Information Officer |
Feb 09 |
Option Exercise |
$164.44 |
893 |
146,845 |
9,233 |
4 |
Feb 12, 05:20 PM |
| Pawlicki Raymond |
SVP, Chief Information Officer |
Feb 08 |
Option Exercise |
$164.44 |
523 |
86,002 |
8,236 |
4 |
Feb 12, 05:20 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 09 |
Option Exercise |
$164.44 |
1,275 |
209,661 |
13,117 |
4 |
Feb 12, 05:12 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 08 |
Option Exercise |
$164.44 |
702 |
115,437 |
10,483 |
4 |
Feb 12, 05:12 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 09 |
Option Exercise |
$164.44 |
1,836 |
301,912 |
17,388 |
4 |
Feb 12, 05:10 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 08 |
Option Exercise |
$164.44 |
1,133 |
186,311 |
14,532 |
4 |
Feb 12, 05:10 PM |
| WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 08 |
Option Exercise |
$164.44 |
1,252 |
205,879 |
8,939 |
4 |
Feb 12, 05:08 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Feb 09 |
Option Exercise |
$164.44 |
3,723 |
612,210 |
46,958 |
4 |
Feb 12, 05:05 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Feb 10 |
Option Exercise |
$164.44 |
8,890 |
1,461,872 |
56,901 |
4 |
Feb 12, 05:05 PM |
| PANGIA ROBERT W |
Director |
Feb 06 |
Option Exercise |
$66.29 |
2,500 |
165,725 |
21,098 |
4 |
Feb 07, 01:58 PM |
| PANGIA ROBERT W |
Director |
Feb 06 |
Sale |
$165.55 |
2,500 |
413,875 |
18,598 |
4 |
Feb 07, 01:58 PM |
| Pawlicki Raymond |
SVP, Chief Information Officer |
Feb 06 |
Option Exercise |
$49.65 |
10,000 |
496,500 |
17,653 |
4 |
Feb 07, 01:55 PM |
| Pawlicki Raymond |
SVP, Chief Information Officer |
Feb 06 |
Sale |
$165.55 |
10,000 |
1,655,500 |
7,653 |
4 |
Feb 07, 01:55 PM |
| WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 01 |
Option Exercise |
$157.30 |
1,679 |
264,107 |
7,185 |
4 |
Feb 05, 06:23 PM |
| Holtzman Steven H |
EVP Corporate Development |
Feb 01 |
Option Exercise |
$157.30 |
1,678 |
263,949 |
6,982 |
4 |
Feb 05, 04:25 PM |
| DiPietro Kenneth |
EVP Human Resources |
Feb 01 |
Option Exercise |
$157.30 |
711 |
111,840 |
1,440 |
4 |
Feb 05, 04:23 PM |
| DENNER ALEXANDER J |
Director |
Dec 27 |
Sale |
$148.36 |
3,991 |
592,086 |
6,220 |
4 |
Dec 28, 10:15 AM |
| DENNER ALEXANDER J |
Director |
Dec 26 |
Sale |
$148.89 |
3,989 |
593,914 |
8,911 |
4 |
Dec 28, 10:15 AM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Nov 01 |
Sale |
$139.42 |
2,472 |
344,640 |
52,898 |
4 |
Nov 02, 03:49 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Oct 01 |
Sale |
$149.16 |
3,654 |
545,031 |
54,142 |
4 |
Oct 02, 01:10 PM |
| PANGIA ROBERT W |
Director |
Sep 17 |
Option Exercise |
$66.29 |
5,000 |
331,450 |
23,598 |
4 |
Sep 18, 05:26 PM |
| PANGIA ROBERT W |
Director |
Sep 17 |
Sale |
$155.00 |
5,000 |
775,000 |
18,598 |
4 |
Sep 18, 05:26 PM |
| PANGIA ROBERT W |
Director |
Sep 06 |
Option Exercise |
$66.29 |
5,000 |
331,450 |
23,598 |
4 |
Sep 10, 02:20 PM |
| PANGIA ROBERT W |
Director |
Sep 06 |
Sale |
$150.00 |
5,000 |
750,000 |
18,598 |
4 |
Sep 10, 02:20 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Aug 02 |
Sale |
$142.99 |
1,165 |
166,583 |
9,020 |
4 |
Aug 03, 11:12 AM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Aug 01 |
Sale |
$146.30 |
3,655 |
534,727 |
61,450 |
4 |
Aug 02, 03:24 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Jul 27 |
Option Exercise |
$57.04 |
58,070 |
3,312,157 |
68,255 |
4 |
Jul 30, 02:58 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Jul 27 |
Sale |
$150.00 |
58,070 |
8,710,500 |
10,185 |
4 |
Jul 30, 02:58 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Jul 17 |
Sale |
$146.04 |
2,472 |
361,011 |
66,333 |
4 |
Jul 18, 03:35 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Jul 16 |
Option Exercise |
$144.61 |
17,679 |
2,556,560 |
76,357 |
4 |
Jul 17, 01:03 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Jul 02 |
Sale |
$143.50 |
1,183 |
169,761 |
63,917 |
4 |
Jul 03, 10:40 AM |
| Pawlicki Raymond |
SVP, Chief Information Officer |
Jun 19 |
Option Exercise |
$49.59 |
10,000 |
495,900 |
17,653 |
4 |
Jun 21, 11:41 AM |
| Pawlicki Raymond |
SVP, Chief Information Officer |
Jun 19 |
Sale |
$143.00 |
10,000 |
1,430,000 |
7,653 |
4 |
Jun 21, 11:41 AM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Jun 15 |
Option Exercise |
$47.87 |
49,800 |
2,383,838 |
59,985 |
4 |
Jun 18, 01:53 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Jun 15 |
Sale |
$140.00 |
49,800 |
6,972,000 |
10,185 |
4 |
Jun 18, 01:53 PM |
| PANGIA ROBERT W |
Director |
Jun 15 |
Option Exercise |
$36.94 |
5,000 |
184,700 |
23,598 |
4 |
Jun 18, 01:50 PM |
| PANGIA ROBERT W |
Director |
Jun 15 |
Sale |
$140.00 |
5,000 |
700,000 |
18,598 |
4 |
Jun 18, 01:50 PM |
| Posner Brian S |
Director |
Jun 07 |
Option Exercise |
$71.38 |
2,500 |
178,450 |
15,130 |
4 |
Jun 11, 11:22 AM |
| Posner Brian S |
Director |
Jun 07 |
Sale |
$135.00 |
2,500 |
337,500 |
12,630 |
4 |
Jun 11, 11:22 AM |
| PANGIA ROBERT W |
Director |
Jun 04 |
Option Exercise |
$36.94 |
5,000 |
184,700 |
21,578 |
4 |
Jun 05, 03:45 PM |
| PANGIA ROBERT W |
Director |
Jun 04 |
Sale |
$130.00 |
5,000 |
650,000 |
16,578 |
4 |
Jun 05, 03:45 PM |
| SHERWIN STEPHEN A |
Director |
Jun 04 |
Sale |
$126.45 |
2,500 |
316,125 |
4,135 |
4 |
Jun 05, 03:43 PM |
| Posner Brian S |
Director |
Jun 04 |
Option Exercise |
$71.38 |
2,400 |
171,312 |
15,030 |
4 |
Jun 05, 03:41 PM |
| Posner Brian S |
Director |
Jun 04 |
Sale |
$126.45 |
2,400 |
303,480 |
12,630 |
4 |
Jun 05, 03:41 PM |
| Pawlicki Raymond |
SVP, Chief Information Officer |
Jun 04 |
Sale |
$126.45 |
1,068 |
135,049 |
7,653 |
4 |
Jun 05, 03:39 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Jun 01 |
Sale |
$128.63 |
1,183 |
152,169 |
65,100 |
4 |
Jun 04, 04:26 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
May 03 |
Option Exercise |
$134.26 |
765 |
102,709 |
12,178 |
4 |
May 04, 02:03 PM |
| Pawlicki Raymond |
SVP, Chief Information Officer |
May 03 |
Option Exercise |
$134.26 |
765 |
102,709 |
8,721 |
4 |
May 04, 02:02 PM |
| SCHENK LYNN |
Director |
May 02 |
Option Exercise |
$53.43 |
5,975 |
319,244 |
8,875 |
4 |
May 03, 04:46 PM |
| SCHENK LYNN |
Director |
May 02 |
Sale |
$135.00 |
8,480 |
1,144,800 |
7,100 |
4 |
May 03, 04:46 PM |
| SCHENK LYNN |
Director |
May 02 |
Sale |
$135.00 |
5,975 |
806,625 |
2,900 |
4 |
May 03, 04:46 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
May 02 |
Option Exercise |
$44.73 |
20,000 |
894,600 |
30,185 |
4 |
May 03, 04:34 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
May 02 |
Sale |
$135.00 |
20,000 |
2,700,000 |
10,185 |
4 |
May 03, 04:34 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Apr 25 |
Option Exercise |
$44.73 |
16,764 |
749,854 |
26,949 |
4 |
Apr 26, 03:44 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Apr 25 |
Sale |
$130.00 |
16,764 |
2,179,320 |
10,185 |
4 |
Apr 26, 03:44 PM |
| PANGIA ROBERT W |
Director |
Mar 08 |
Option Exercise |
$35.21 |
7,500 |
264,050 |
21,578 |
4 |
Mar 12, 03:02 PM |
| PANGIA ROBERT W |
Director |
Mar 08 |
Sale |
$120.00 |
7,500 |
900,000 |
16,578 |
4 |
Mar 12, 03:02 PM |
| Gagnon Robert E. |
Vice President, Finance |
Feb 29 |
Sale |
$115.51 |
717 |
82,821 |
4,356 |
4 |
Mar 01, 03:23 PM |
| Gagnon Robert E. |
Vice President, Finance |
Feb 28 |
Sale |
$115.03 |
835 |
96,050 |
4,716 |
4 |
Mar 01, 03:23 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 27 |
Sale |
$115.43 |
4,255 |
491,155 |
12,302 |
4 |
Feb 28, 04:01 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 24 |
Option Exercise |
$116.39 |
2,601 |
302,730 |
15,747 |
4 |
Feb 27, 04:20 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 23 |
Option Exercise |
$116.70 |
1,413 |
164,897 |
19,186 |
4 |
Feb 27, 04:20 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 24 |
Sale |
$115.53 |
2,145 |
247,812 |
17,447 |
4 |
Feb 27, 04:20 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 23 |
Option Exercise |
$116.70 |
1,085 |
126,619 |
14,291 |
4 |
Feb 27, 04:19 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 24 |
Option Exercise |
$116.39 |
1,578 |
183,663 |
13,506 |
4 |
Feb 27, 04:19 PM |
| Gagnon Robert E. |
Vice President, Finance |
Feb 23 |
Option Exercise |
$116.70 |
388 |
45,280 |
5,885 |
4 |
Feb 27, 04:18 PM |
| Gagnon Robert E. |
Vice President, Finance |
Feb 24 |
Option Exercise |
$116.39 |
334 |
38,874 |
5,719 |
4 |
Feb 27, 04:18 PM |
| Gagnon Robert E. |
Vice President, Finance |
Feb 24 |
Option Exercise |
$49.65 |
1,054 |
52,331 |
6,939 |
4 |
Feb 27, 04:18 PM |
| Gagnon Robert E. |
Vice President, Finance |
Feb 24 |
Sale |
$115.53 |
1,054 |
121,769 |
5,885 |
4 |
Feb 27, 04:18 PM |
| Clancy Paul J |
Executive VP and CFO |
Feb 24 |
Option Exercise |
$116.39 |
2,786 |
324,263 |
25,012 |
4 |
Feb 27, 04:17 PM |
| Clancy Paul J |
Executive VP and CFO |
Feb 23 |
Option Exercise |
$116.70 |
1,786 |
208,426 |
26,398 |
4 |
Feb 27, 04:17 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Jul 15 |
Option Exercise |
$104.00 |
8,791 |
914,264 |
54,374 |
4/A |
Feb 22, 12:03 PM |
| Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 14 |
Sale |
$118.61 |
1,247 |
147,907 |
0 |
4 |
Feb 16, 02:39 PM |
| Gagnon Robert E. |
Vice President, Finance |
Feb 14 |
Sale |
$118.61 |
560 |
66,422 |
5,050 |
4 |
Feb 16, 02:37 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 13 |
Sale |
$118.01 |
2,842 |
335,384 |
16,777 |
4 |
Feb 14, 03:58 PM |
| Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 09 |
Option Exercise |
$117.78 |
579 |
68,195 |
1,247 |
4 |
Feb 14, 03:57 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 09 |
Option Exercise |
$117.78 |
1,504 |
177,141 |
12,776 |
4 |
Feb 13, 04:28 PM |
| Gagnon Robert E. |
Vice President, Finance |
Feb 09 |
Option Exercise |
$117.78 |
301 |
35,452 |
5,610 |
4 |
Feb 13, 04:27 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 09 |
Option Exercise |
$117.78 |
1,257 |
148,049 |
19,619 |
4 |
Feb 13, 04:26 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Feb 10 |
Option Exercise |
$118.14 |
7,007 |
827,807 |
66,283 |
4 |
Feb 13, 04:24 PM |
| Clancy Paul J |
Executive VP and CFO |
Feb 09 |
Option Exercise |
$117.78 |
1,957 |
230,495 |
23,903 |
4 |
Feb 13, 04:21 PM |
| Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 06 |
Sale |
$121.03 |
3,110 |
376,403 |
0 |
4 |
Feb 08, 03:07 PM |
| Clancy Paul J |
Executive VP and CFO |
Feb 01 |
Option Exercise |
$52.95 |
21,400 |
1,133,088 |
42,568 |
4 |
Feb 03, 02:56 PM |
| Clancy Paul J |
Executive VP and CFO |
Feb 01 |
Sale |
$120.00 |
21,400 |
2,568,000 |
29,568 |
4 |
Feb 03, 02:56 PM |
| WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 01 |
Option Exercise |
$121.26 |
1,656 |
200,807 |
3,906 |
4 |
Feb 03, 02:55 PM |
| Holtzman Steven H |
EVP Corp Devel and Strategy |
Feb 01 |
Option Exercise |
$121.26 |
1,658 |
201,049 |
3,501 |
4 |
Feb 03, 02:54 PM |
| Granata Francesco |
EVP Global Commercial Operatio |
Feb 01 |
Option Exercise |
$121.26 |
1,669 |
202,383 |
3,529 |
4 |
Feb 03, 02:53 PM |
| Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 01 |
Option Exercise |
$121.26 |
1,477 |
179,101 |
3,110 |
4 |
Feb 03, 02:52 PM |
| LEAMING NANCY |
Director |
Feb 01 |
Option Exercise |
$59.17 |
5,700 |
337,269 |
12,035 |
4 |
Feb 03, 02:51 PM |
| LEAMING NANCY |
Director |
Feb 01 |
Sale |
$120.00 |
5,700 |
684,000 |
6,335 |
4 |
Feb 03, 02:51 PM |
| LEAMING NANCY |
Director |
Jan 20 |
Option Exercise |
$55.97 |
3,000 |
167,910 |
9,335 |
4 |
Jan 24, 03:55 PM |
| LEAMING NANCY |
Director |
Jan 20 |
Sale |
$118.00 |
3,000 |
354,000 |
6,335 |
4 |
Jan 24, 03:55 PM |
| LEAMING NANCY |
Director |
Jan 06 |
Option Exercise |
$55.97 |
3,000 |
167,910 |
9,335 |
4 |
Jan 09, 03:54 PM |
| LEAMING NANCY |
Director |
Jan 06 |
Sale |
$116.00 |
3,000 |
348,000 |
6,335 |
4 |
Jan 09, 03:54 PM |
| Rowinsky Eric K |
Director |
Jan 06 |
Option Exercise |
$59.82 |
12,992 |
777,181 |
20,802 |
4 |
Jan 09, 03:52 PM |
| Rowinsky Eric K |
Director |
Jan 06 |
Sale |
$116.00 |
12,992 |
1,507,072 |
9,135 |
4 |
Jan 09, 03:52 PM |
| LEAMING NANCY |
Director |
Jan 03 |
Option Exercise |
$55.97 |
4,000 |
223,880 |
10,335 |
4 |
Jan 04, 01:27 PM |
| LEAMING NANCY |
Director |
Jan 03 |
Sale |
$114.00 |
4,000 |
456,000 |
6,335 |
4 |
Jan 04, 01:27 PM |
| Clancy Paul J |
Executive VP and CFO |
Jan 03 |
Sale |
$112.35 |
20,244 |
2,274,401 |
26,742 |
4 |
Jan 04, 01:24 PM |
| SHERWIN STEPHEN A |
Director |
Dec 19 |
Sale |
$110.88 |
2,500 |
277,200 |
6,635 |
4 |
Dec 20, 03:10 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Dec 06 |
Sale |
$112.31 |
795 |
89,286 |
5,050 |
4 |
Dec 08, 02:05 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Dec 01 |
Option Exercise |
$116.48 |
371 |
43,214 |
5,845 |
4 |
Dec 02, 02:10 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Nov 09 |
Sale |
$112.04 |
796 |
89,184 |
6,216 |
4 |
Nov 14, 11:26 AM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Nov 02 |
Option Exercise |
$113.43 |
371 |
42,083 |
7,012 |
4 |
Nov 04, 11:50 AM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 01 |
Option Exercise |
$72.87 |
2,175 |
158,492 |
11,763 |
4 |
Nov 03, 10:52 AM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 01 |
Sale |
$114.37 |
2,175 |
248,755 |
9,588 |
4 |
Nov 03, 10:52 AM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Oct 05 |
Sale |
$97.66 |
252 |
24,610 |
7,383 |
4 |
Oct 07, 01:48 PM |
| YOUNG WILLIAM |
Director |
Sep 27 |
Option Exercise |
$51.38 |
33,250 |
1,708,441 |
60,109 |
4 |
Sep 29, 01:01 PM |
| YOUNG WILLIAM |
Director |
Sep 27 |
Sale |
$96.14 |
33,250 |
3,196,655 |
26,859 |
4 |
Sep 29, 01:01 PM |
| LEAMING NANCY |
Director |
Sep 16 |
Sale |
$100.00 |
3,085 |
308,500 |
6,335 |
4 |
Sep 19, 05:18 PM |
| YOUNG WILLIAM |
Director |
Sep 01 |
Option Exercise |
$46.68 |
35,000 |
1,633,775 |
61,859 |
4 |
Sep 02, 12:45 PM |
| YOUNG WILLIAM |
Director |
Sep 01 |
Sale |
$95.00 |
35,000 |
3,325,000 |
26,859 |
4 |
Sep 02, 12:45 PM |
| Posner Brian S |
Director |
Aug 29 |
Option Exercise |
$71.38 |
15,000 |
1,070,700 |
27,630 |
4 |
Aug 31, 11:44 AM |
| Posner Brian S |
Director |
Aug 29 |
Sale |
$92.53 |
15,000 |
1,387,894 |
12,630 |
4 |
Aug 31, 11:44 AM |
| YOUNG WILLIAM |
Director |
Aug 29 |
Option Exercise |
$68.15 |
10,000 |
681,500 |
36,859 |
4 |
Aug 31, 11:42 AM |
| YOUNG WILLIAM |
Director |
Aug 29 |
Sale |
$92.58 |
10,000 |
925,784 |
26,859 |
4 |
Aug 31, 11:42 AM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Aug 01 |
Option Exercise |
$102.90 |
835 |
85,922 |
18,130 |
4 |
Aug 03, 11:24 AM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Aug 02 |
Sale |
$102.04 |
1,165 |
118,877 |
16,965 |
4 |
Aug 03, 11:24 AM |
| Clancy Paul J |
Executive VP and CFO |
Aug 01 |
Option Exercise |
$102.90 |
835 |
85,922 |
41,412 |
4 |
Aug 03, 11:23 AM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Jul 20 |
Sale |
$106.51 |
12,347 |
1,315,033 |
64,164 |
4 |
Jul 21, 02:30 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Jul 15 |
Option Exercise |
$104.00 |
8,911 |
926,744 |
66,804 |
4 |
Jul 19, 04:29 PM |
| SCANGOS GEORGE A |
Chief Executive Officer |
Jul 14 |
Option Exercise |
$104.00 |
8,791 |
914,264 |
54,374 |
4 |
Jul 19, 04:29 PM |
| Posner Brian S |
Director |
May 25 |
Option Exercise |
$67.25 |
25,975 |
1,746,844 |
35,705 |
4 |
May 27, 03:15 PM |
| Posner Brian S |
Director |
May 25 |
Sale |
$94.09 |
25,975 |
2,444,027 |
22,900 |
4 |
May 27, 03:15 PM |
| LEAMING NANCY |
Director |
May 26 |
Option Exercise |
$55.51 |
33,175 |
1,841,628 |
41,995 |
4 |
May 27, 03:13 PM |
| LEAMING NANCY |
Director |
May 26 |
Sale |
$93.05 |
33,175 |
3,087,085 |
13,451 |
4 |
May 27, 03:13 PM |
| PANGIA ROBERT W |
Director |
May 26 |
Option Exercise |
$56.88 |
15,000 |
853,200 |
29,080 |
4 |
May 27, 03:11 PM |
| PANGIA ROBERT W |
Director |
May 26 |
Sale |
$93.11 |
15,000 |
1,396,647 |
16,280 |
4 |
May 27, 03:11 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
May 06 |
Sale |
$96.13 |
967 |
92,960 |
7,753 |
4 |
May 09, 04:38 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
May 03 |
Option Exercise |
$97.99 |
450 |
44,095 |
8,935 |
4 |
May 04, 02:53 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
May 04 |
Sale |
$96.03 |
215 |
20,646 |
8,720 |
4 |
May 04, 02:53 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
May 03 |
Option Exercise |
$97.99 |
765 |
74,962 |
9,588 |
4 |
May 04, 02:51 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
May 01 |
Option Exercise |
$97.65 |
101 |
9,863 |
9,385 |
4 |
May 03, 01:03 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
May 02 |
Sale |
$97.20 |
20,993 |
2,040,497 |
35,834 |
4 |
May 03, 01:01 PM |
| Clancy Paul J |
Executive VP and CFO |
Apr 28 |
Option Exercise |
$41.18 |
14,766 |
608,119 |
57,202 |
4 |
Apr 29, 03:03 PM |
| Clancy Paul J |
Executive VP and CFO |
Apr 28 |
Sale |
$98.91 |
19,716 |
1,950,088 |
48,497 |
4 |
Apr 29, 03:03 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Apr 21 |
Option Exercise |
$72.87 |
4,350 |
316,985 |
14,703 |
4 |
Apr 25, 02:02 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Apr 21 |
Sale |
$100.00 |
4,350 |
435,000 |
10,353 |
4 |
Apr 25, 02:02 PM |
| SCHENK LYNN |
Director |
Apr 20 |
Option Exercise |
$61.84 |
37,275 |
2,304,947 |
35,255 |
4 |
Apr 21, 04:41 PM |
| SCHENK LYNN |
Director |
Apr 20 |
Sale |
$85.22 |
37,275 |
3,176,461 |
7,980 |
4 |
Apr 21, 04:41 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Apr 13 |
Option Exercise |
$56.73 |
36,234 |
2,055,646 |
46,587 |
4 |
Apr 15, 11:50 AM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Apr 13 |
Sale |
$80.00 |
36,234 |
2,898,720 |
10,353 |
4 |
Apr 15, 11:50 AM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Apr 11 |
Option Exercise |
$47.92 |
6,900 |
330,648 |
17,253 |
4 |
Apr 13, 10:14 AM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Apr 11 |
Sale |
$78.00 |
6,900 |
538,200 |
10,353 |
4 |
Apr 13, 10:14 AM |
| Clancy Paul J |
Executive VP and CFO |
Mar 05 |
Option Exercise |
$71.15 |
25,888 |
1,841,931 |
47,197 |
4 |
Apr 08, 10:38 AM |
| Clancy Paul J |
Executive VP and CFO |
Mar 05 |
Option Exercise |
$58.99 |
28,750 |
1,695,963 |
73,085 |
4 |
Apr 08, 10:38 AM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Mar 31 |
Option Exercise |
$43.50 |
2,840 |
123,540 |
12,658 |
4 |
Apr 01, 03:20 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Mar 31 |
Sale |
$73.00 |
2,840 |
207,320 |
9,818 |
4 |
Apr 01, 03:20 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Mar 01 |
Option Exercise |
$49.65 |
6,250 |
310,313 |
23,962 |
4 |
Mar 03, 03:17 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Mar 02 |
Sale |
$70.10 |
7,511 |
526,552 |
13,633 |
4 |
Mar 03, 03:17 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Mar 01 |
Sale |
$68.62 |
6,250 |
428,875 |
17,712 |
4 |
Mar 03, 03:17 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Mar 02 |
Sale |
$70.10 |
4,041 |
283,259 |
12,401 |
4 |
Mar 03, 03:10 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Mar 02 |
Sale |
$70.02 |
1,402 |
98,164 |
10,788 |
4 |
Mar 03, 03:08 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 24 |
Option Exercise |
$67.26 |
1,980 |
133,175 |
40,953 |
4 |
Feb 28, 03:41 PM |
| Clancy Paul J |
Executive VP and CFO |
Feb 24 |
Option Exercise |
$67.26 |
2,164 |
145,551 |
45,401 |
4 |
Feb 28, 03:39 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Feb 24 |
Option Exercise |
$67.26 |
335 |
22,532 |
11,056 |
4 |
Feb 28, 03:36 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Feb 24 |
Option Exercise |
$67.26 |
2,156 |
145,013 |
18,707 |
4 |
Feb 28, 03:34 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 24 |
Option Exercise |
$67.26 |
1,202 |
80,847 |
14,463 |
4 |
Feb 28, 03:32 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 23 |
Option Exercise |
$66.76 |
680 |
45,397 |
15,190 |
4 |
Feb 25, 03:56 PM |
| Clancy Paul J |
Executive VP and CFO |
Feb 23 |
Option Exercise |
$66.76 |
1,119 |
74,704 |
46,711 |
4 |
Feb 25, 03:55 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Feb 23 |
Option Exercise |
$66.76 |
320 |
21,363 |
11,284 |
4 |
Feb 25, 03:54 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Feb 24 |
Option Exercise |
$49.65 |
1,054 |
52,331 |
12,277 |
4 |
Feb 25, 03:54 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Feb 24 |
Sale |
$66.99 |
1,054 |
70,606 |
11,223 |
4 |
Feb 25, 03:54 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Feb 23 |
Option Exercise |
$66.76 |
1,598 |
106,682 |
20,171 |
4 |
Feb 25, 03:53 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Feb 25 |
Option Exercise |
$49.31 |
9,725 |
479,540 |
29,593 |
4 |
Feb 25, 03:53 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Feb 25 |
Sale |
$68.20 |
9,725 |
663,245 |
19,868 |
4 |
Feb 25, 03:53 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 23 |
Option Exercise |
$66.76 |
999 |
66,693 |
42,128 |
4 |
Feb 25, 03:51 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Feb 17 |
Sale |
$67.10 |
732 |
49,115 |
10,537 |
4 |
Feb 18, 03:09 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Feb 17 |
Sale |
$67.08 |
3,194 |
214,242 |
16,436 |
4 |
Feb 18, 03:07 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 17 |
Sale |
$67.08 |
1,843 |
123,620 |
13,603 |
4 |
Feb 18, 03:06 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Feb 12 |
Option Exercise |
$65.83 |
1,486 |
97,823 |
19,630 |
4 |
Feb 15, 02:31 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Feb 12 |
Option Exercise |
$65.83 |
341 |
22,448 |
11,269 |
4 |
Feb 15, 02:29 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 12 |
Option Exercise |
$65.83 |
910 |
59,905 |
15,446 |
4 |
Feb 15, 02:27 PM |
| Clancy Paul J |
Executive VP and CFO |
Feb 12 |
Option Exercise |
$65.83 |
1,686 |
110,989 |
44,097 |
4 |
Feb 15, 02:26 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 12 |
Option Exercise |
$65.83 |
1,515 |
99,732 |
39,793 |
4 |
Feb 15, 02:24 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Jan 20 |
Option Exercise |
$49.65 |
6,250 |
310,313 |
27,366 |
4 |
Jan 24, 02:59 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Jan 20 |
Sale |
$68.62 |
6,250 |
428,875 |
21,116 |
4 |
Jan 24, 02:59 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Jan 04 |
Option Exercise |
$46.07 |
4,307 |
198,415 |
12,514 |
4 |
Jan 05, 02:45 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Jan 04 |
Sale |
$66.57 |
5,103 |
339,690 |
10,814 |
4 |
Jan 05, 02:45 PM |
| YOUNG WILLIAM |
Director |
Dec 31 |
Option Exercise |
$67.05 |
13,256 |
888,815 |
21,059 |
4 |
Jan 04, 03:58 PM |
| YOUNG WILLIAM |
Director |
Dec 31 |
Option Exercise |
$59.25 |
15,000 |
888,750 |
34,315 |
4 |
Jan 04, 03:58 PM |
| SCHENK LYNN |
Director |
Dec 30 |
Option Exercise |
$59.25 |
15,000 |
888,750 |
22,980 |
4 |
Jan 03, 09:57 AM |
| SCHENK LYNN |
Director |
Dec 30 |
Sale |
$66.80 |
15,000 |
1,001,988 |
7,980 |
4 |
Jan 03, 09:57 AM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Dec 17 |
Option Exercise |
$49.31 |
19,450 |
959,080 |
40,566 |
4 |
Dec 21, 03:32 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Dec 17 |
Sale |
$68.20 |
19,450 |
1,326,490 |
21,116 |
4 |
Dec 21, 03:32 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Dec 06 |
Sale |
$66.53 |
796 |
52,957 |
11,610 |
4 |
Dec 07, 05:14 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Dec 03 |
Option Exercise |
$44.24 |
1,907 |
84,366 |
23,023 |
4 |
Dec 07, 05:13 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Dec 07 |
Option Exercise |
$44.24 |
28,093 |
1,242,834 |
49,209 |
4 |
Dec 07, 05:13 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Dec 03 |
Sale |
$67.20 |
1,907 |
128,150 |
21,116 |
4 |
Dec 07, 05:13 PM |
| SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Dec 07 |
Sale |
$67.20 |
28,093 |
1,887,850 |
21,116 |
4 |
Dec 07, 05:13 PM |
| Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Dec 01 |
Option Exercise |
$65.37 |
371 |
24,252 |
12,406 |
4 |
Dec 03, 01:46 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 09 |
Sale |
$62.87 |
773 |
48,597 |
16,356 |
4 |
Nov 10, 02:21 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 09 |
Sale |
$62.87 |
773 |
48,597 |
16,356 |
4 |
Nov 10, 02:21 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 01 |
Option Exercise |
$62.55 |
360 |
22,518 |
17,894 |
4 |
Nov 03, 01:50 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 01 |
Option Exercise |
$62.55 |
360 |
22,518 |
17,894 |
4 |
Nov 03, 01:50 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 02 |
Sale |
$63.04 |
765 |
48,228 |
17,129 |
4 |
Nov 03, 01:50 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 02 |
Sale |
$63.04 |
765 |
48,228 |
17,129 |
4 |
Nov 03, 01:50 PM |
| PANGIA ROBERT W |
Director |
Oct 28 |
Option Exercise |
$59.25 |
15,000 |
888,750 |
29,080 |
4 |
Oct 29, 02:27 PM |
| PANGIA ROBERT W |
Director |
Oct 28 |
Sale |
$64.00 |
15,000 |
960,000 |
14,080 |
4 |
Oct 29, 02:27 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Oct 28 |
Option Exercise |
$33.97 |
6,900 |
234,393 |
25,154 |
4 |
Oct 29, 02:25 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Oct 28 |
Option Exercise |
$33.97 |
6,900 |
234,393 |
25,154 |
4 |
Oct 29, 02:25 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Oct 28 |
Sale |
$63.00 |
6,900 |
434,700 |
18,254 |
4 |
Oct 29, 02:25 PM |
| Cox John |
EVP Pharmaceutical Oper & Tech |
Oct 28 |
Sale |
$63.00 |
6,900 |
434,700 |
18,254 |
4 |
Oct 29, 02:25 PM |
| Clancy Paul J |
Executive VP and CFO |
Sep 04 |
Option Exercise |
$56.24 |
1,114 |
62,651 |
45,783 |
4 |
Sep 07, 04:05 PM |
| DORSA CAROLINE |
Director |
Aug 13 |
Buy |
$56.41 |
177 |
9,985 |
8,243 |
4 |
Aug 17, 04:35 PM |
| MacLean Michael F |
SVP, Chief Accounting Officer |
Aug 02 |
Sale |
$56.85 |
9,542 |
542,457 |
20,494 |
4 |
Aug 03, 04:03 PM |
| MacLean Michael F |
SVP, Chief Accounting Officer |
Aug 02 |
Sale |
$56.85 |
9,542 |
542,457 |
20,494 |
4 |
Aug 03, 04:03 PM |
| Clancy Paul J |
Executive VP and CFO |
Aug 01 |
Option Exercise |
$55.88 |
835 |
46,660 |
46,897 |
4 |
Aug 03, 04:01 PM |
| ALEXANDER SUSAN H |
EVP, General Counsel |
Aug 01 |
Option Exercise |
$55.88 |
835 |
46,660 |
41,308 |
4 |
Aug 03, 04:00 PM |
| DORSA CAROLINE |
Director |
Jul 30 |
Buy |
$54.57 |
183 |
9,986 |
8,066 |
4 |
Aug 03, 03:58 PM |
